Pharmaceutics (Feb 2023)

Glycomimetic Peptides as Therapeutic Tools

  • J. Kenneth Hoober,
  • Laura L. Eggink

DOI
https://doi.org/10.3390/pharmaceutics15020688
Journal volume & issue
Vol. 15, no. 2
p. 688

Abstract

Read online

The entry of peptides into glycobiology has led to the development of a unique class of therapeutic tools. Although numerous and well-known peptides are active as endocrine regulatory factors that bind to specific receptors, and peptides have been used extensively as epitopes for vaccine production, the use of peptides that mimic sugars as ligands of lectin-type receptors has opened a unique approach to modulate activity of immune cells. Ground-breaking work that initiated the use of peptides as tools for therapy identified sugar mimetics by screening phage display libraries. The peptides that have been discovered show significant potential as high-avidity, therapeutic tools when synthesized as multivalent structures. Advantages of peptides over sugars as drugs for immune modulation will be illustrated in this review.

Keywords